Complement Fragment C4d and C3d Deposition in Pediatric Heart Receipients With a Positive Crossmatch

Journal of Heart and Lung Transplantation

Volumn 27, Issue 10, 2008, Pages 1073-1078

  Holt, Dudley B ^a   Liapis, Helen ^a   Mohanakumar, Thalchallour ^a   Phelan, Donna R ^a   Gandi, Sanjiv K ^a   Huddleston, Charles B ^a   Canter, Charles E ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CD68 ANTIGEN; COMPLEMENT COMPONENT C3D; COMPLEMENT COMPONENT C4D;

ARTICLE; CELL INFILTRATION; CLINICAL ARTICLE; CONTROLLED STUDY; GRAFT RECIPIENT; GRAFT REJECTION; HEART DISEASE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE BIOPSY; HEART MUSCLE CAPILLARY; HEART TRANSPLANTATION; HUMAN; IMMUNOPEROXIDASE STAINING; MACROPHAGE; PEDIATRIC SURGERY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL;

ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; BIOPSY; CAPILLARIES; CHILD; COMPLEMENT C3D; COMPLEMENT C4B; GRAFT REJECTION; HEART TRANSPLANTATION; HISTOCOMPATIBILITY TESTING; HUMANS; IMMUNOHISTOCHEMISTRY; MACROPHAGE ACTIVATION; PEPTIDE FRAGMENTS; TISSUE DONORS;

EID: 52949150010     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2008.07.013     Document Type: Article

References (34)

1. Takemoto S.K., Zeevi A., Feng S., et al. National conference to assess antibody-mediated rejection in solid organ transplantation. Am J Transplant 4 (2004) 1033-1041
2. Reed E.F., Demetris A.J., Hammond E., et al. Acute antibody-mediated rejection of cardiac transplants. J Heart Lung Transplant 25 (2006) 153-159
3. Poelzl G., Ullrich R., Huber A., et al. Capillary deposition of the complement fragment C4d in cardiac allograft biopsies is associated with allograft vasculopathy. Transplant Int 18 (2005) 313-317
4. Crespo-Leiro M.G., Veiga-Barreiro A., Domenech N., et al. Humoral heart rejection (severe allograft dysfunction with no signs of cellular rejection or ischemia): incidence, management, and the value of C4d for diagnosis. Am J Transplant 5 (2005) 2560-2564
5. Rodriquez E.R., Skojec D.V., Tan C.D., et al. Antibody-mediated rejection in human cardiac allografts: evaluation of immunoglobulins and complement activation products C4d and C3d as markers. Am J Transplant 5 (2005) 2778-2785
6. Baldwin W.M., Samaniego-Picota M., Kasper E.K., et al. Complement deposition in early cardiac transplant biopsies is associated with ischemic injury and subsequent rejection episodes. Transplantation 68 (1999) 894-900
7. Azzawi M., Kan S.W., Hillier V., et al. The distribution of cardiac macrophages in myocardial ischemia and cardiomyopathy. Histopathology 46 (2005) 314-319
8. Stewart S., Winters G.L., Fishbein M.C., et al. Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. J Heart Lung Transplant 24 (2005) 1710-1720
9. Hawkins J.A., Breinholt J.P., Lambert L.M., et al. Class I and class II anti-HLA antibodies after implantation of cryopreserved allograft material in pediatric patients. J Thorac Cardiovasc Surg 119 (2000) 324-330
10. Mahle W.T., Vincent R.N., and Kanter K.R. Cardiac retransplantation in childhood: analysis of data from the United Network for Organ Sharing. J Thorac Cardiovasc Surg 130 (2005) 542-546
11. McKenna Jr. D.H., Eastlund T., Segall M., Noreen H.J., and Park S. HLA alloimmunization in patients requiring ventricular assist device support. J Heart Lung Transplant 21 (2002) 1218-1224
12. Holt D.B., Lublin D.M., Phelan D.R., et al. Mortality and morbidity in presensitized pediatric heart transplant recipients with a positive donor crossmatch utilizing perioperative plasmapheresis and cytolytic therapy. J Heart Lung Transplant 26 (2007) 876-882
13. Canter C.E., Moorhead S., Saffitz J.E., Huddleston C.B., and Spray T.L. Steroid withdrawal in the pediatric heart transplant recipient initially treated with triple immunosuppression. J Heart Lung Transplant 13 (1994) 74-79
14. McOmber D., Ibrahim J., Lublin D.M., et al. Non-ischemic left ventricular dysfunction after pediatric cardiac transplantation: treatment with plasmapheresis and OKT3. J Heart Lung Transplant 23 (2004) 552-557
15. Book W.M., Kelley L., and Gravanis M.B. Fulminant mixed humoral and cellular rejection in a cardiac transplant recipient: a review of the histologic findings and the literature. J Heart Lung Transplant 22 (2003) 604-607
16. Pisani B.A., Mullen M., Malinoska K., et al. Plasmapheresis with intravenous immunoglobulin G is effective in patients with elevated panel reactive antibody prior to cardiac transplantation. J Heart Lung Transplant 18 (1999) 701-706
17. Jacobs J.A., Quintessenza J.A., Boucek R.J., et al. Pediatric cardiac transplantation in children with high panel reactive antibody. Ann Thorac Surg 78 (2004) 1703-1709
18. Leech S.H., Lopez-Cepero M., LeFor W.M., et al. Management of the sensitized cardiac recipient: the use of plasmapheresis and intravenous immunoglobulin. Clin Transplant 20 (2006) 476-484
19. Yasojima K., Schwab C., McGeer E.G., and McGeer P.L. Generation of C-reactive protein and complement components in atherosclerotic plaques. Am J Pathol 158 (2001) 1039-1051
20. Dorling A., Stocker C., Tsao T., Haskard D.O., and Lechler R.I. In vitro accommodation of immortalized porcine endothelial cells: resistance to complement mediated lysis and down-regulation of VCAM expression induced by low concentrations of polyclonal human IgG antipig antibodies. Transplantation 62 (1996) 1127-1136
21. Shibata T., Cosio F.G., and Birmingham D.J. Complement activation induces the expression of decay-accelerating factor on human mesangial cells. J Immunol 147 (1991) 3901-3908
22. Galambos C. Feingold B, Webber SA. Characterization of C4d immunostain utilizing paraffin-embedded tissue of non-presensitized pediatric cardiac transplant patients. World Transplant Congress;(suppl).
23. Patel J.K., Itagaki B., Ankrom A., et al. Hemodynamic compromise rejection: does the heart biopsy influence outcome?. J Heart Lung Transplant 27 suppl (2008) S169
24. Rahimi S., Qian Z., Layton J., et al. Non-complement- and complement-activating antibodies synergize to cause rejection of cardiac allografts. Am J Transplant 4 (2004) 326-334
25. Rodriguez E.R., Skojec D.V., Tan C.D., et al. Antibody-mediated rejection in human cardiac allografts: evaluation of immunoglobulins and complement activation products C4d and C3d as markers. Am J Transplant 5 (2005) 2778-2785
26. Behr T.M., Feucht H.E., Richter K., et al. Detection of humoral rejection in human cardiac allografts by assessing the capillary deposition of complement fragment C4d in endomyocardial biopsies. J Heart Lung Transplant 18 (1999) 904-912
27. Chantranuwat C., Qiao J., Kobashigawa J., Hong L., Shintaku P., and Fishbein M.C. Immunoperoxidase staining for C4d on paraffin-embedded tissue in cardiac allograft endomyocardial biopsies. Appl Immunohistochem Mol Morphol 12 (2004) 166-171
28. Baldwin W.M., Qian Z., Ota H., et al. Complement as a mediator of vascular inflammation and activation in allografts. J Heart Lung Transplant 19 (2000) 723-730
29. Williams J.M., Holzknecht Z.E., Plummer T.B., et al. Acute vascular rejection and accomodation: divergent outcomes of the humoral response to organ transplantation. Transplantation 78 (2004) 1471-1478
30. Ross C.N., Gaskin G., Gregor-Macgregor S., et al. Renal transplantation following immunoadsorption in highly sensitized recipients. Transplantation 55 (1993) 785-789
31. Narayanan K., Jaramillo A., Phelan D.L., and Mohanakumar T. Pre-exposure to sub-saturating concentrations of HLA class I antibodies confers resistance to endothelial cells against antibody complement-mediated lysis by regulating Bad through the phosphatidylinositol 3-kinase/Akt pathway. Eur J Immunol 34 (2004) 2303-2312
32. Girnita A., Webber S.A., and Zeevi A. Anti-HLA alloantibodies in pediatric solid organ transplantation. Pediatr Transplant 10 (2006) 146-153
33. Wehner J., Morrell D.N., Reynolds T., Rodriguez E.R., and Baldwin W.M. Antibody and complement in transplant vasculopathy. Circ Res 100 (2007) 191-203
34. Longhi M.P., Harris C.L., Morgan B.P., and Gallimore A. Holding T cells in check-a new role for complement regulators?. Trends Immunol 27 (2006) 102-108